Apollo Hospitals Enterprise Limited

rs,

LS lQth February 2025 The Secretary, Bombay Stock Exchange Ltd (BSE) Phiroze Jheejheebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code - 508869 ISIN INE437A01024 Dear Sir, 'G' Block T

13%

Y(%) EBITDA(Post Ind AS) Margin Growth YoY(%) PAT Growth YoY(%) Healthcare Services 27,850 13% 6,706 24.1% 14% 3,483 12.5% 21% o C h t l a e H o l l o p A Offline PD ^ 20,786 14%

24.1%

Post Ind AS) Margin Growth YoY(%) PAT Growth YoY(%) Healthcare Services 27,850 13% 6,706 24.1% 14% 3,483 12.5% 21% o C h t l a e H o l l o p A Offline PD ^ 20,786 14% 1,593 7.7%

14%

d AS) Margin Growth YoY(%) PAT Growth YoY(%) Healthcare Services 27,850 13% 6,706 24.1% 14% 3,483 12.5% 21% o C h t l a e H o l l o p A Offline PD ^ 20,786 14% 1,593 7.7% 19%

12.5%

Growth YoY(%) PAT Growth YoY(%) Healthcare Services 27,850 13% 6,706 24.1% 14% 3,483 12.5% 21% o C h t l a e H o l l o p A Offline PD ^ 20,786 14% 1,593 7.7% 19% Online PD^ & 2

21%

h YoY(%) PAT Growth YoY(%) Healthcare Services 27,850 13% 6,706 24.1% 14% 3,483 12.5% 21% o C h t l a e H o l l o p A Offline PD ^ 20,786 14% 1,593 7.7% 19% Online PD^ & 24|7

7.7%

24.1% 14% 3,483 12.5% 21% o C h t l a e H o l l o p A Offline PD ^ 20,786 14% 1,593 7.7% 19% Online PD^ & 24|7 2,737 22% (1,027) Vs (1,322) in Q3F24 Total HealthCo 23,524 15%

19%

14% 3,483 12.5% 21% o C h t l a e H o l l o p A Offline PD ^ 20,786 14% 1,593 7.7% 19% Online PD^ & 24|7 2,737 22% (1,027) Vs (1,322) in Q3F24 Total HealthCo 23,524 15% 566

22%

l a e H o l l o p A Offline PD ^ 20,786 14% 1,593 7.7% 19% Online PD^ & 24|7 2,737 22% (1,027) Vs (1,322) in Q3F24 Total HealthCo 23,524 15% 566 2.4% 321 1.4% AHLL 3,895

15%

7.7% 19% Online PD^ & 24|7 2,737 22% (1,027) Vs (1,322) in Q3F24 Total HealthCo 23,524 15% 566 2.4% 321 1.4% AHLL 3,895 15% 342 8.8% 32% (80) Consolidated 55,269 14% 7,61

2.4%

Online PD^ & 24|7 2,737 22% (1,027) Vs (1,322) in Q3F24 Total HealthCo 23,524 15% 566 2.4% 321 1.4% AHLL 3,895 15% 342 8.8% 32% (80) Consolidated 55,269 14% 7,615 13.8% 2

1.4%

24|7 2,737 22% (1,027) Vs (1,322) in Q3F24 Total HealthCo 23,524 15% 566 2.4% 321 1.4% AHLL 3,895 15% 342 8.8% 32% (80) Consolidated 55,269 14% 7,615 13.8% 24% 3,723

“Chennai Tel Telefax Email Website : www.apollohospitals.com : 044 - 2829 0956 I 3896 I 6681 : 044 - 2829 0956 : investor.relations@apollohospitals.com Apollo Hospitals Enterprise Limited Earnings Update Q3 FY25 • Disclaimer The information contained in this presentation is provided by Apollo Hospitals Enterprise Limited (the “Company”) to you solely for your reference.”

“You acknowledge that you will be solely responsible for your own assessment of the market and the market position of the Company and that you will conduct your own analysis and be solely responsible for forming your own view of the potential future performance of the business of the Company.”

“Healthcare Services Q3 FY25 Snapshot 150,986 In-patients 5% Revenue ` 27,850 Mio 13% ₹ 162,957 Avg Revenue per IP Patient 7% EBITDA ` 6,706 Mio 14% ₹ 60,839 / day ARPOB2 8% Margin 24.1% 68% Occupancy © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 2ARPOB is net of fees paid to “fee for service doctors” which is netted off in the Reported Revenues.”

“Expect to start sourcing business by Q4 exit.”

“Test- menu expected to cross 2,400+ tests by the end of FY25  Cradle: ~15% YoY revenue growth in 9M’FY25.”

“gross realization per patient (INR)* Network Growth – Collection Centers # Operational footprint (as of Dec 31, 2024) ~330+ ~330+ ~330+ Cities Cities presence Cities presence presence 103 Labs 827 806 811 +180 2,330 2,263 731 731 15,143 14,753 13,697 16,205 2,041 14,420 2,221 2,221+ Collection Centres 2,102 Q3 FY24 Q4 FY24 Footfalls / Day* Q1 FY25 Q2 FY25 Gross ARPV (Rs.) Q3 FY25 1.”

“EBITDA post IND AS 116; * Footfalls and ARPV for diagnostics represent outpatient / external business © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved Q1 FY25 Q4 FY24 Q3 FY24 # Rationalized the commission structure for collection centers, resulting in reduction of centers in Q2 FY25.”

“Q3 FY25 Q2 FY25 3,000+ Pick-up Points (PUPs) 28 • Digital Health & Pharmacy Distribution Apollo HealthCo © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 29 India’s Largest Omni-Channel Healthcare Platform Apollo 247 Digital Platform Apollo Pharmacy Platform ~38 Mn+ Registrations n hi Manish - ,r; Book Apollo Doctor Appoinlmc,nl ~10,100 Doctors , >) >~ ii .t.”

“Omnichannel Pharmacy (AHL+ APL) Business revenue of Rs 29,904 Mn in Q3’ FY25 compared to a revenue of Rs.”

“Platform GMV : Rs 7,599 Mn in Q3’ FY25, growth of 11% over Q3’ FY24 New customer channel started to gain traction (launch of 19 mins across 4 cities) Continuous Improvement in quantitative parameters in Q3’ FY25 vs Q3’ FY24: o 25% YoY growth in Online Pharma delivered orders.”

Digital Operational Metrics

2

Regd. Office

1

General Office

1

Omnichannel Healthcare Division

1

General Office

"Ali Towers" Ill Floor, #55, Greams Road, - 600 006. Chennai Tel Telefax Email Website : www.apollohospitals.com : 044 - 2829 0956 I 3896 I 6681 : 044 - 2829 0956 : investor.relations@apollohospitals.com Apollo Hospitals Enterprise Limited Earnings Update Q3 FY25 • Disclaimer The information contained in this presentation is provided by Apollo Hospitals Enterprise Limited (the “Company”) to you solely for your reference. This document is being given solely for your information and for your use and may not be retained by you and neither this presentation nor any part thereof may be (i) used or relied upon by any other party or for any other purpose; (ii) copied, photocopied, duplicated or otherwise reproduced in any form or by any means; or (iii) redistributed, passed on or otherwise disseminated, to any other person without the prior written consent of the Company. Although care has been taken to ensure that the information in this presentation is accurate, and that the opinions expres

Omnichannel Healthcare Division

Omnichannel Pharmacy (AHL+ APL) Business revenue of Rs 29,904 Mn in Q3’ FY25 compared to a revenue of Rs. 25,835 Mn in Q3’ FY24 (growth of 15.8%). Apollo Telehealth (under AHEL) Revenues of Rs.167 Mn in Q3FY25 (growth of 9%)

Digital Operational Metrics

Platform GMV : Rs 7,599 Mn in Q3’ FY25, growth of 11% over Q3’ FY24 New customer channel started to gain traction (launch of 19 mins across 4 cities) Continuous Improvement in quantitative parameters in Q3’ FY25 vs Q3’ FY24: o 25% YoY growth in Online Pharma delivered orders. o DAU Dec exit shows YoY growth of 25% Healthco Cash profit* (in Mn) 5X 161 677 835 Offline Segment * Excluding 24|7 operating Cost and ESOP Non-Cash Charge Digital Cash loss* (in Mn) Q3'FY24 Q2'FY25 Q3'FY25 -1,184 -854 -758 36% Q3'FY24 Q2'FY25 Q3'FY25 *Cash loss/profit is EBITDA post Ind As excluding ESOP expense © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved o 12.2% YoY growth in offline transactions (8.04 cr Vs 7.17 cr year back). O Serving ~8.7 lac offline customers per day 31 ` MioOffline Pharmacy Distribution Online Pharmacy Distribution & Apollo 247Total HealthCoTotal Revenues20,7862,73823,524EBITDA (Pre 24|7 Cost)1,5933781,972margin (%) 7.7%13.8%8.4%24/7 Operating Cost-1,137-1,137ESOP(Non Cash

Digital Operational Metrics

Platform GMV : Rs 22,117 Mn in YTD FY25, growth of 7% over YTD ’ FY24 Offline Segment o 12.5% YoY growth in offline transactions (22.8 cr Vs 20.3 cr year back). * Excluding 24|7 operating Cost and ESOP Non-Cash Charge © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 32 ` MioOffline Pharmacy Distribution Online Pharmacy Distribution & Apollo 247Total HealthCoTotal Revenues59,2997,86867,167EBITDA (Pre 24|7 Cost)4,5081,0595,567margin (%) 7.6%13.5%8.3%24/7 Operating Cost-3,634-3,634ESOP(Non Cash expense)-621-621EBITDA 4,508-3,1961,312margin (%) 7.6%-2.0%EBIT897PBT382PAT (Reported)382Total Revenues51,3886,61458,002EBITDA (Pre 24|7 Cost)3,8947414,635margin (%) 7.6%11.2%8.0%24/7 Operating Cost-4,784-4,784ESOP(Non Cash expense)-785-785EBITDA 3,894-4,828-934margin (%) 7.6%--EBIT-1,303PBT-1,777PAT (Reported)-1,779Revenue15%19%16%EBITDA (Pre 24|7 Cost)16%43%20%YTD Dec24YTD Dec23 Apollo HealthCo : Advent Investment - Tranche 1 of INR 1732 crs completed • Apollo Healthco Limited (“AHL”)